- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04270448
Effects of Feedback on Learning of a Motor Sequence Task
July 18, 2021 updated by: Jill Stewart, PT, PhD, University of South Carolina
Feedback delivered during motor practice can help promote motor skill learning and promote confidence.
However, the optimal way to provide feedback to promote learning and confidence is unknown.
This project will study how the feedback that is provided during practice of a movement skill can help people learn and build confidence.
The investigators will measure motor skill performance and confidence before and after a session of motor practice.
Study Overview
Detailed Description
Feedback may be a useful tool to optimize motor learning during practice.
For example, feedback during practice that indicates the learner is performing above average (i.e.
positive social comparative feedback) enhances motor skill learning and self-efficacy in healthy adults.
While this type of feedback is hypothesized to promote learning in some tasks, no studies have examined whether positive social comparative feedback during practice promotes motor learning in a traditional motor sequence task.
Therefore, the aim of the proposed project is to investigate the effect of positive social comparative feedback on the learning of a joystick-based motor sequence task in healthy adults.
The study aims to recruit 60 participants who will be randomized into 1 of 3 feedback groups (control group, performance feedback, and performance plus positive feedback).
Participants will practice a motor sequence task on a single day and then return for retention performance testing about 24 hours later.
Changes in performance (response time to complete a sequence) and self-efficacy will be measured from baseline to 24 hours later at retention.
Study Type
Interventional
Enrollment (Actual)
54
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
South Carolina
-
Columbia, South Carolina, United States, 29208
- University of South Carolina
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age 18 to 40 years
- Right-hand dominant
Exclusion Criteria:
- Medical diagnosis or medication that affects dopamine (e.g. dopamine reuptake inhibitors)
- musculoskeletal issues that limit upper extremity movement
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Performance Feedback
Practice of a joystick based motor sequence task.
Participants receive feedback on their response time to complete the trials in the practice block.
|
Participants will be seated at a laptop with the right hand on a standard joystick.
The movement of the joystick will move a cursor on the computer screen.
Targets will appear on the laptop screen as a circle in one of twelve spatially distinct locations.
The learner must move the joystick "cursor" to inside the target before the next target will appear.
|
Experimental: Performance plus Positive Feedback
Practice of a joystick based motor sequence task.
Participants receive feedback on their response time to complete the trials in the practice block plus positive social comparative feedback.
|
Participants will be seated at a laptop with the right hand on a standard joystick.
The movement of the joystick will move a cursor on the computer screen.
Targets will appear on the laptop screen as a circle in one of twelve spatially distinct locations.
The learner must move the joystick "cursor" to inside the target before the next target will appear.
|
Active Comparator: Control
Practice of a joystick based motor sequence task.
Participants receive feedback that they have completed the practice trials in that block of practice.
|
Participants will be seated at a laptop with the right hand on a standard joystick.
The movement of the joystick will move a cursor on the computer screen.
Targets will appear on the laptop screen as a circle in one of twelve spatially distinct locations.
The learner must move the joystick "cursor" to inside the target before the next target will appear.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Response Time
Time Frame: Change from baseline to retention at 24 hours
|
Time to complete one sequence
|
Change from baseline to retention at 24 hours
|
Task Confidence
Time Frame: Change from baseline to retention at 24 hours
|
Self-reported confidence in ability to complete a sequence in a given time on a scale of 0 to 10 with a 10 equating to higher confidence
|
Change from baseline to retention at 24 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Peak Velocity
Time Frame: Change from baseline to retention at 24 hours
|
Average speed to capture a target within a sequence
|
Change from baseline to retention at 24 hours
|
Total Path Distance
Time Frame: Change from baseline to retention at 24 hours
|
Total distance traveled to complete one sequence
|
Change from baseline to retention at 24 hours
|
Time to Peak Velocity
Time Frame: Change from baseline to retention at 24 hours
|
Mean time to peak velocity for movement to a target within a sequence
|
Change from baseline to retention at 24 hours
|
Perceived Competence
Time Frame: Change from baseline to retention at 24 hours
|
Mean score on the Perceived Competence subscale of the Intrinsic Motivation Inventory where each item ranges from 0 to 7 with a higher value equating to higher competence
|
Change from baseline to retention at 24 hours
|
Perceived Interest/Enjoyment
Time Frame: Change from baseline to retention at 24 hours
|
Mean score on the Interest/Enjoyment subscale of the Intrinsic Motivation Inventory where each item ranges from 0 to 7 with a higher value equating to higher enjoyment
|
Change from baseline to retention at 24 hours
|
Positive Affect
Time Frame: Change from baseline to retention at 24 hours
|
Total score for general positive affect on the Positive and Negative Affect Scale with a range from 10 to 50 with higher scores equating to higher positive affect
|
Change from baseline to retention at 24 hours
|
Peak Velocity
Time Frame: Change from baseline to immediately after practice
|
Average speed to capture a target within a sequence
|
Change from baseline to immediately after practice
|
Total Path Distance
Time Frame: Change from baseline to immediately after practice
|
Total distance traveled to complete one sequence
|
Change from baseline to immediately after practice
|
Time to Peak Velocity
Time Frame: Change from baseline to immediately after practice
|
Mean time to peak velocity for movement to a target within a sequence
|
Change from baseline to immediately after practice
|
Perceived Competence
Time Frame: Change from baseline to immediately after practice
|
Mean score on the Perceived Competence subscale of the Intrinsic Motivation Inventory where each item ranges from 0 to 7 with a higher value equating to higher competence
|
Change from baseline to immediately after practice
|
Perceived Interest/Enjoyment
Time Frame: Change from baseline to immediately after practice
|
Mean score on the Interest/Enjoyment subscale of the Intrinsic Motivation Inventory where each item ranges from 0 to 7 with a higher value equating to higher enjoyment
|
Change from baseline to immediately after practice
|
Positive Affect
Time Frame: Change from baseline to immediately after practice
|
Total score for general positive affect on the Positive and Negative Affect Scale with a range from 10 to 50 with higher scores equating to higher positive affect
|
Change from baseline to immediately after practice
|
Response Time
Time Frame: Change from baseline to immediately after practice
|
Time to complete one sequence
|
Change from baseline to immediately after practice
|
Task Confidence
Time Frame: Change from baseline to immediately after practice
|
Self-reported confidence in ability to complete a sequence in a given time on a scale of 0 to 10 with a 10 equating to higher confidence
|
Change from baseline to immediately after practice
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 5, 2020
Primary Completion (Actual)
April 30, 2021
Study Completion (Actual)
April 30, 2021
Study Registration Dates
First Submitted
February 4, 2020
First Submitted That Met QC Criteria
February 11, 2020
First Posted (Actual)
February 17, 2020
Study Record Updates
Last Update Posted (Actual)
July 20, 2021
Last Update Submitted That Met QC Criteria
July 18, 2021
Last Verified
July 1, 2021
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- Pro00095119
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
De-identified data will be made available per reasonable request to the principal investigator 1 year after study completion.
IPD Sharing Time Frame
1 year after study completion
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Adult
-
Ethicon Endo-SurgeryRecruitingPediatric Procedures | Adult Hepato-pancreato-biliary (HPB) Procedures | Adult Lower Gastrointestinal Procedures | Adult Gastric Procedures | Adult Gynecological Procedures | Adult Urological Procedures | Adult Thoracic ProceduresUnited States, Canada, United Kingdom
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingAdult Anaplastic Astrocytoma | Adult Anaplastic Ependymoma | Adult Anaplastic Oligodendroglioma | Adult Diffuse Astrocytoma | Adult Ependymoma | Adult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Adult Mixed Glioma | Adult Myxopapillary Ependymoma | Adult Oligodendroglioma | Adult Pilocytic... and other conditionsUnited States
-
National Cancer Institute (NCI)TerminatedAdult Anaplastic Astrocytoma | Adult Anaplastic Ependymoma | Adult Anaplastic Oligodendroglioma | Adult Diffuse Astrocytoma | Adult Ependymoma | Adult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Adult Mixed Glioma | Adult Myxopapillary Ependymoma | Adult Oligodendroglioma | Adult Pilocytic... and other conditionsUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Millennium Pharmaceuticals, Inc.CompletedAdult Anaplastic Astrocytoma | Adult Anaplastic Ependymoma | Adult Anaplastic Oligodendroglioma | Adult Diffuse Astrocytoma | Adult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Adult Mixed Glioma | Adult Oligodendroglioma | Adult Pilocytic Astrocytoma | Adult Pineal Gland Astrocytoma | Recurrent... and other conditionsUnited States
-
National Cancer Institute (NCI)TerminatedAdult Anaplastic Astrocytoma | Adult Anaplastic Ependymoma | Adult Anaplastic Oligodendroglioma | Adult Diffuse Astrocytoma | Adult Ependymoma | Adult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Adult Mixed Glioma | Adult Myxopapillary Ependymoma | Adult Oligodendroglioma | Adult Pilocytic... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedAdult Anaplastic Astrocytoma | Adult Diffuse Astrocytoma | Adult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Adult Mixed Glioma | Adult Oligodendroglioma | Adult Pineal Gland AstrocytomaUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)CompletedAdvanced Adult Hepatocellular Carcinoma | Localized Non-Resectable Adult Liver Carcinoma | Adult Hepatocellular Carcinoma | BCLC Stage B Adult Hepatocellular Carcinoma | BCLC Stage C Adult Hepatocellular Carcinoma | BCLC Stage D Adult Hepatocellular Carcinoma | Localized Resectable Adult Liver... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedAdult Anaplastic Astrocytoma | Adult Anaplastic Oligodendroglioma | Adult Diffuse Astrocytoma | Adult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Adult Mixed Glioma | Adult Pilocytic Astrocytoma | Adult Pineal Gland Astrocytoma | Recurrent Adult Brain Tumor | Adult Subependymal Giant...United States
-
University of CalgaryCanadian Institutes of Health Research (CIHR); Canadian Cancer Society (CCS)Recruiting
-
National Cancer Institute (NCI)CompletedAdult Anaplastic Astrocytoma | Adult Anaplastic Oligodendroglioma | Adult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Adult Mixed Glioma | Recurrent Adult Brain TumorUnited States
Clinical Trials on Motor Sequence Task
-
University of South CarolinaCompleted
-
Johns Hopkins UniversityNational Institute of Mental Health (NIMH)RecruitingEffects of Cerebellar Stimulation on Brain ActivationUnited States
-
George Washington UniversityRecruiting
-
University of PlymouthRecruiting
-
University of PittsburghNational Institute on Aging (NIA)CompletedGait Disorder, Sensorimotor | Cognitive DisorderUnited States
-
Yeditepe UniversityRecruiting
-
Tan Tock Seng HospitalNational Neuroscience Institute; Nanyang PolytechnicRecruitingMild Cognitive ImpairmentSingapore
-
National Cheng-Kung University HospitalCompletedRehabilitation, Tenodesis, StrokeTaiwan
-
Centre Hospitalier Universitaire de Saint EtienneTerminated
-
Laboratoire Interuniversitaire de Biologie de la...Unknown